Skip to Main Content
Tomoaki Terakawa
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Avelumab plus Axitinib for the Treatment of Patients with End-Stage Renal Disease Undergoing Dialysis: A Retrospective Case Series and Literature Review

Subject Area:
Further Areas , ADC (Antibody-Drug Conjugates) , Karger e-Journal Backfile Collection 2023
Yukari Bando, Junya Furukawa, Takuto Hara, Yasuyoshi Okamura, Tomoaki Terakawa, Yuzo Nakano, Masato Fujisawa
Journal: Urologia Internationalis
Urol Int (2023) 107 (3): 321–326.
https://doi.org/10.1159/000528447
Published Online: 22 March 2023
View article titled, Avelumab plus Axitinib for the Treatment of Patients with End-Stage Renal Disease Undergoing Dialysis: A Retrospective Case Series and Literature Review
Open the PDF for Avelumab plus Axitinib for the Treatment of Patients with End-Stage Renal Disease Undergoing Dialysis: A Retrospective Case Series and Literature Review in another window
Journal Articles

The Efficacy of Surgical Metastasectomy for Solitary Metastasis of Renal Cell Carcinoma

Subject Area:
Further Areas
Kotaro Suzuki, Takuto Hara, Tomoaki Terakawa, Junya Furukawa, Kenichi Harada, Nobuyuki Hinata, Yuzo Nakano, Masato Fujisawa
Journal: Urologia Internationalis
Urol Int (2022) 106 (4): 397–403.
https://doi.org/10.1159/000516679
Published Online: 16 June 2021
View article titled, The Efficacy of Surgical Metastasectomy for Solitary Metastasis of Renal Cell Carcinoma
Open the PDF for The Efficacy of Surgical Metastasectomy for Solitary Metastasis of Renal Cell Carcinoma in another window
Journal Articles

Clinical Outcome of Paclitaxel and Carboplatin as Second-Line Chemotherapy for Advanced Urothelial Carcinoma Resistant to First-Line Therapy with Gemcitabine and Cisplatin

Subject Area:
Further Areas
Tomoaki Terakawa, Hideaki Miyake, Naoki Yokoyama, Akira Miyazaki, Hiroyuki Tanaka, Takaaki Inoue, Masato Fujisawa
Journal: Urologia Internationalis
Urol Int (2014) 92 (2): 180–185.
https://doi.org/10.1159/000354149
Published Online: 13 November 2013
View article titled, Clinical Outcome of Paclitaxel and Carboplatin as Second-Line Chemotherapy for Advanced Urothelial Carcinoma Resistant to First-Line Therapy with Gemcitabine and Cisplatin
Open the PDF for Clinical Outcome of Paclitaxel and Carboplatin as Second-Line Chemotherapy for Advanced Urothelial Carcinoma Resistant to First-Line Therapy with Gemcitabine and Cisplatin in another window
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal